Continuous CO2 monitoring has traditionally required bulky, complex hospital machinery. UK charity and MedTech startup Keep Me Breathing is set to disrupt that paradigm with Vento—a wearable monitor engineered to be 90% lighter and 20 times smaller than traditional clinical hardware.
In this Med-Tech Insights video interview, Editor Oli Johnson speaks with James Oakley, founder and CEO of Keep Me Breathing. Following the team’s 1,000-mile validation challenge across Europe, James breaks down the engineering behind this non-invasive breakthrough, how a parent-led charity operates like an agile medical device developer, and the five-year roadmap toward a revolutionary diaphragm pacer.
Subscribe to Med-Tech Insights for updates on medical device innovation, regulatory shifts, and healthtech breakthroughs – https://account.med-technews.com/register
